BESSY II: New insights into switchable MOF structures at the MX beamlines
View into a MOF crystal exemplified by DUT-8. The massive pores are clearly discernible. © TU Dresden
Metal-organic framework compounds (MOFs) are widely used in gas storage, material separation, sensor technology or catalysis. A team led by Prof. Dr. Stefan Kaskel, TU Dresden, has now investigated a special class of these MOFs at the MX beamlines of BESSY II. These are "switchable" MOFs that can react to external stimuli. Their analysis shows how the behaviour of the material is related to transitions between ordered and disordered phases. The results have now been published in Nature Chemistry.
Metal-organic framework compounds (MOFs) consist of inorganic and organic groups and are characterised by a large number of pores into which other molecules can be incorporated. MOFs are therefore interesting for many applications, for example for the storage of gases, but also for substance separation, sensor technology or catalysis. Some of these MOF structures react to different guest molecules by changing their structures. They are thus considered switchable.
One of these is "DUT-8", a material that has now been studied at the MX beamlines of BESSY II. "MOF crystals can be analysed very well at the MX beamlines," says HZB expert Dr. Manfred Weiss, who heads the MX team. “MOF crystals have many things in common with protein crystals. For example, both are interspersed with large pores, which are filled with liquid in the protein crystals, while those in MOFs provide space for guest molecules," Weiss explains.
"The diffraction patterns that DUT-8 showed on the HZB-MX beamlines were extremely complex. We were now able to attribute this to various transitions between ordered and less ordered phases," explains Stefan Kaskel. The enclosed guest molecule directs the network into one of over a thousand possible disorder configurations. The results contribute to a better understanding of switching processes and gas exchange reactions in such MOF structures, so that future functional MOF materials can be developed in a targeted manner.
The investigations were supported by the DFG programme (FOR2433).
- Green hydrogen: MXenes shows talent as catalyst for oxygen evolutionThe MXene class of materials has many talents. An international team led by HZB chemist Michelle Browne has now demonstrated that MXenes, properly functionalised, are excellent catalysts for the oxygen evolution reaction in electrolytic water splitting. They are more stable and efficient than the best metal oxide catalysts currently available. The team is now extensively characterising these MXene catalysts for water splitting at the Berlin X-ray source BESSY II and Soleil Synchrotron in France.
- SpinMagIC: 'EPR on a chip' ensures quality of olive oil and beerThe first sign of spoilage in many food products is the formation of free radicals, which reduces the shelf-life and the overall quality of the food. Until now, the detection of these molecules has been very costly for the food companies. Researchers at HZB and the University of Stuttgart have developed a portable, small and inexpensive 'EPR on a chip' sensor that can detect free radicals even at very low concentrations. They are now working to set up a spin-off company, supported by the EXIST research transfer programme of the German Federal Ministry of Economics and Climate Protection. The EPRoC sensor will initially be used in the production of olive oil and beer to ensure the quality of these products.
- Review on ocular particle therapy (OPT) by international expertsA team of leading experts in medical physics, physics and radiotherapy, including HZB physicist Prof. Andrea Denker and Charité medical physicist Dr Jens Heufelder, has published a review article on ocular particle therapy. The article appeared in the Red Journal, one of the most prestigious journals in the field. It outlines the special features of this form of eye therapy, explains the state of the art and current research priorities, provides recommendations for the delivery of radiotherapy and gives an outlook on future developments.